Changes in Hypertension Treatment in the Yaroslavl Region of Russia: Improvements Observed Between 2 Cross-Sectional Surveys
Version of Record online: 9 OCT 2013
© 2013 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals, Inc on behalf of the American Society of Hypertension, Inc.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
The Journal of Clinical Hypertension
Volume 15, Issue 12, pages 918–924, December 2013
How to Cite
J Clin Hypertens (Greenwich). 2013;15:918–924. DOI: 10.1111/jch.12214. ©2013 Wiley Periodicals, Inc.
- Issue online: 3 DEC 2013
- Version of Record online: 9 OCT 2013
- Manuscript Accepted: 13 SEP 2013
- Manuscript Revised: 21 AUG 2013
- Manuscript Received: 25 JUN 2013
- Novartis Pharma LLC Russia
- Novartis International AG, Basel, Switzerland
This prospective before-and-after survey of hypertensive patients visiting government-run outpatient health facilities in the Yaroslavl Region of Russia assessed blood pressure (BP)–related endpoints following initiation of a comprehensive health system improvement program for hypertension. Two cross-sectional surveys, one at baseline and the other approximately 1 year after program initiation, evaluated the primary measure of BP control rate. Secondary measures included mean BP levels and distribution, cardiovascular risk factors, and associated conditions, heart rate levels, and antihypertensive therapy. From the 2011 survey (n=1794) to the 2012 survey (n=2992), BP control rate (<140/90 mm Hg) significantly increased from 16.8% to 23.0%, reflecting a 37% relative improvement (P<.0001). Mean BP level was significantly reduced from 151/90 mm Hg to 147/88 mm Hg (P<.0001). Severe uncontrolled hypertension (systolic BP ≥180 mm Hg) was reduced from 9.7% to 6.4% (P<.0001). Implementing a guidelines-based treatment protocol with medical and patient education programs resulted in physician behavior change and improved patient BP control.